Cencora, Inc.

COR 10-K · Q4 2025
API behind this page

COR Q4 2025 request

Playground key active
Request URL /api/financials?ticker=COR&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 83,728,554 79,050,106 +5.9%
Show Business Segments breakouts
International Healthcare Solutions · Alliance Healthcare 6,393,679 5,939,265 +7.7%
International Healthcare Solutions · Operating Segments 7,944,988 7,382,054 +7.6%
International Healthcare Solutions · Other Healthcare Solutions 1,551,309 1,442,789 +7.5%
U.S. Healthcare Solutions · Animal Health 1,479,808 1,401,608 +5.6%
U.S. Healthcare Solutions · Human Health 74,308,693 70,269,522 +5.7%
U.S. Healthcare Solutions · Operating Segments 75,788,501 71,671,130 +5.7%
Show Consolidation Items breakouts
Intersegment Elimination -4,935 -3,078 -60.3%
Cost of Revenue 80,774,977 76,557,689 +5.5%
Gross Profit 2,953,577 2,492,417 +18.5%
Selling, General & Administrative 1,748,866 1,490,343 +17.3%
Depreciation Nonproduction 131,486 110,152 +19.4%
Amortization Of Intangible Assets 127,284 166,892 -23.7%
Litigation Settlement Expense 14,408 65,517 -78.0%
Show Consolidation Items breakouts
Material Reconciling Items 14,408 65,517 -78.0%
Business Combination Acquisition Related Costs 100,114 33,570 +198.2%
Show Consolidation Items breakouts
Material Reconciling Items 100,114 33,570 +198.2%
Restructuring Charges 89,032 81,304 +9.5%
Show Consolidation Items breakouts
Material Reconciling Items 89,032 81,304 +9.5%
Operating Income 18,503 126,639 -85.4%
Show Business Segments breakouts
International Healthcare Solutions · Operating Segments 150,658 153,673 -2.0%
U.S. Healthcare Solutions · Operating Segments 872,412 697,384 +25.1%
Show Consolidation Items breakouts
Operating Segments 1,023,070 851,057 +20.2%
Non-Operating Income (Expense) 127,714 -19,507 +754.7%
Interest Income Expense Nonoperating Net 77,833 20,969 +271.2%
Income Before Taxes -187,044 125,177 -249.4%
Income Tax Expense (Benefit) 146,027 117,711 +24.1%
Net Income -333,071 7,466 -4561.2%
Show Equity Components breakouts
Noncontrolling Interest 6,633 4,084 +62.4%
Retained Earnings -339,704 3,382 -10144.5%
Net Income Loss Attributable To Noncontrolling Interest -6,633 -4,084 -62.4%
Net Income -339,704 3,382 -10144.5%
EPS (Basic) -1.75 0.04 -4475.0%
EPS (Diluted) -1.74 0.04 -4450.0%
Wtd Avg Shares (Basic) 26 -750 +103.5%
Wtd Avg Shares (Diluted) 42 -741 +105.7%
Comprehensive Income -396,844 293,433 -235.2%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 4,356,138 3,132,648 +39.1%
Accounts Receivable 25,225,299 23,871,815 +5.7%
Inventory 20,492,480 18,998,833 +7.9%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 303,480 259,299 +17.0%
Contract With Customer Asset Gross Current 1,625,817 1,175,871 +38.3%
Prepaid Expenses & Other Current Assets 539,339 538,646 +0.1%
Total Current Assets 52,239,073 47,717,813 +9.5%
Non-Current Assets
Property, Plant & Equipment 2,539,076 2,181,410 +16.4%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 65,410 49,869 +31.2%
Goodwill 13,676,520 9,318,027 +46.8%
Show Business Segments breakouts
International Healthcare Solutions 2,571,530 3,109,505 -17.3%
U.S. Healthcare Solutions 11,104,990 6,208,522 +78.9%
Deferred Tax Assets 208,810 246,348 -15.2%
Other Non-Current Assets 4,152,452 3,637,023 +14.2%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 99,519 83,765 +18.8%
Total Assets 76,590,112 67,101,667 +14.1%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 909,806 814,673 +11.7%
Operating Lease Right-of-Use Assets 1,548,478 1,141,622 +35.6%
Intangible Assets (Q) — — —
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 3,390,428 3,554,783 -4.6%
Trade names and other 366,753 429,263 -14.6%
Other Assets
Intangible Assets Net Excluding Goodwill 3,774,181 4,001,046 -5.7%
Current Liabilities
Accounts Payable 54,719,761 50,942,162 +7.4%
Accrued Liabilities 2,982,993 2,758,560 +8.1%
Debt Current 117,785 576,331 -79.6%
Total Current Liabilities 57,820,539 54,277,053 +6.5%
Current Portion of Long-Term Debt (Q) — — —
Show Debt Instrument breakouts
Alliance Healthcare debt 1,424 286 +397.9%
Nonrecourse debt 116,361 76,307 +52.5%
Non-Current Liabilities
Long-Term Debt 7,542,988 3,811,745 +97.9%
Accrued Income Taxes Noncurrent 337,631 291,796 +15.7%
Deferred Tax Liabilities 1,620,724 1,643,746 -1.4%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 11,986 19,227 -37.7%
Litigation Reserve Noncurrent 3,881,283 4,296,902 -9.7%
Other Non-Current Liabilities 3,639,862 1,993,683 +82.6%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 75,132 61,690 +21.8%
Long-Term Debt 7,660,773 4,388,076 +74.6%
Show Debt Instrument breakouts
$1,000,000, 2.700% senior notes due 2031 993,838 992,718 +0.1%
$500,000, 2.800% senior notes due 2030 497,174 496,564 +0.1%
$500,000, 4.250% senior notes due 2045 495,792 495,574 0.0%
$500,000, 4.300% senior notes due 2047 494,088 493,821 +0.1%
$500,000, 4.625% senior notes due 2027 497,309 — —
$500,000, 5.125% senior notes due 2034 495,104 494,514 +0.1%
$600,000, 4.850% senior notes due 2029 596,603 — —
$700,000, 5.150% senior notes due 2035 694,909 — —
$750,000, 3.450% senior notes due 2027 748,150 747,308 +0.1%
Alliance Healthcare debt 1,424 286 +397.9%
Nonrecourse debt 181,751 167,553 +8.5%
Term loan due in 2027 799,043 — —
€500,000, 2.875% senior notes due 2028 583,903 — —
€500,000, 3.625% senior notes due 2032 581,685 — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 65,390 91,246 -28.3%
Operating Lease Liabilities 1,416,633 1,029,978 +37.5%
Total Liabilities (Q) — — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 690,128 612,269 +12.7%
Other Liabilities
Minority Interest 239,066 140,804 +69.8%
Stockholders' Equity
Common Stock 2,974 2,962 +0.4%
Additional Paid In Capital Common Stock 6,204,302 6,030,790 +2.9%
Retained Earnings 6,534,227 5,417,139 +20.6%
Accumulated Other Comprehensive Income -901,378 -989,118 +8.9%
Treasury Stock Common Value -10,332,106 -9,815,835 -5.3%
Total Stockholders' Equity 1,508,019 645,938 +133.5%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -901,378 -989,118 +8.9%
Accumulated Translation Adjustment -903,078 -988,484 +8.6%
Other, net 1,700 -634 +368.1%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1,747,085 786,742 +122.1%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -901,378 -989,118 +8.9%
Additional Paid In Capital 6,204,302 6,030,790 +2.9%
Common Stock 2,974 2,962 +0.4%
Noncontrolling Interest 239,066 140,804 +69.8%
Retained Earnings 6,534,227 5,417,139 +20.6%
Treasury Stock Common -10,332,106 -9,815,835 -5.3%
Total Liabilities & Equity 76,590,112 67,101,667 +14.1%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation 133,728 111,245 +20.2%
Adjustment For Amortization 130,270 168,506 -22.7%
Provision For Doubtful Accounts 17,792 10,618 +67.6%
Deferred Income Taxes 55,389 3,752 +1376.3%
Stock-Based Compensation 25,943 34,588 -25.0%
Inventory L I F O Reserve Period Charge -56,962 12,273 -564.1%
Show Consolidation Items breakouts
Material Reconciling Items -56,963 12,273 -564.1%
Inflationary Accounting Impact 12,660 10,645 +18.9%
Equity Investment Remeasurement Gain Loss 16,501 -8,551 +293.0%
Other Non-Cash Items -3,594 8,315 -143.2%
Change in Accounts Receivable -945,803 301,224 -414.0%
Change in Inventory -319,548 -643,966 +50.4%
Change in Prepaid & Other Assets -63,957 -2,801 -2183.4%
Change in Accounts Payable 3,755,256 855,551 +338.9%
Increase Decrease In Income Taxes Payable And Other Liabilities -86,278 -106,621 +19.1%
Net Cash from Operations 3,133,417 1,000,379 +213.2%
Investing Activities
Capital Expenditures -249,812 -182,324 -37.0%
Payments To Acquire Businesses Net Of Cash Acquired -91,410 -45,284 -101.9%
Payments To Acquire Equity Method Investments -2,450 -15,449 +84.1%
Payments To Acquire Notes Receivable 0 0 —
Other Investing Activities 21,732 1,172 +1754.3%
Net Cash from Investing -321,940 -241,885 -33.1%
Financing Activities
Proceeds From Issuance Of Debt 0 0 —
Repayments Of Long Term Debt -517,203 -3,270 -15716.6%
Proceeds From Lines Of Credit 45,980,788 13,019,698 +253.2%
Repayments Of Lines Of Credit -46,045,822 -13,369,959 -244.4%
Proceeds From Stock Options Exercised 6,520 6,280 +3.8%
Payments Of Dividends Common Stock -107,512 -100,945 -6.5%
Tax Withholding for Share Compensation -109 -3,379 +96.8%
Proceeds From Payments For Other Financing Activities -444 -706 +37.1%
Net Cash from Financing -683,782 -957,260 +28.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -8,472 20,250 -141.8%
Net Change in Cash 2,119,223 -178,516 +1287.1%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 4,394,549 3,297,880 +33.3%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 70,796 58,082 +21.9%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key